创美药业股份有限公司（02289）于2026年9月1日发布2026年8月的股份变动月报表。报告显示，截至2026年8月31日，公司无任何新增股份发行、购回或注销及库藏股变动，股本保持稳定。
创美药业股份有限公司的注册股本维持在人民币1元面值的普通股108,000,000股，总计人民币108,000,000元，已发行股份总数与上月底保持一致，为108,000,000股；库藏股份仍为0股。
月报同时显示，创美药业股份有限公司已确认截至2026年8月末继续符合香港联合交易所有限公司对于公众持股量的相关规定。公司报告期内未发生任何股份期权或股权激励计划的授予、行使或变动，亦无购回或注销事项。
本次月报由公司秘书姚洁晞于2026年9月1日签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.